🎯 July marks the first anniversary of PRECISEU, a key European project for personalised medicine coordinated by Biocat.
After 12 months of work, the PRECISEU project, funded by Horizon Europe, has taken its first major steps toward building a more efficient and equitable health innovation ecosystem across Europe.
🌍 PRECISEU brings together 25 partners from 12 European regions to bridge the innovation gap and accelerate the adoption of disruptive health technologies. The project focuses on strengthening regional collaboration, unlocking the potential of health data, streamlining access to ATMPs, and defining a common European model for personalised medicine.
📈 In its first year, PRECISEU has mapped ecosystem capacities, defined impact success indicators, and fostered a shared vision among stakeholders, from researchers to policymakers. These foundations set the stage for stronger cross-border collaboration and the development of scalable solutions that address real patient needs.
🗺️ You still have time to add your organization to the ATMP Pan EU Map. This initiative aims to map Advanced Therapy Medicinal Product (#ATMP) capacities across Europe.
👉 Learn more and explore the full project scope: https://lnkd.in/dMHZcZ63
Project members: Biocat, BioRegion of Catalonia, Generalitat de Catalunya (Departament de Salut), Barcelona Supercomputing Center, bioRN Life Science Cluster, BIOPRO Baden-Württemberg GmbH, North-East Regional Development Agency / Agentia pentru Dezvoltare Regionala Nord-Est, Digital Innovation Zone EDIH, IMAGO-MOL Cluster, Health and Life Sciences Cluster Bulgaria - BioCluster.bg, Sofia Investment Agency, Clust-ER Health - Emilia-Romagna, Regione Emilia-Romagna, ART-ER S. cons. p. a., Departement WEWIS – economie, wetenschap en innovatie, Biovia, Inovacijų agentūra, Business Region Göteborg AB, EATRIS, Plataforma de Organizaciones de Pacientes, ACCIÓ, Foundation for Research and Technology - Hellas (FORTH), Sahlgrenska Science Park, Rivne interregional medical cluster, AstraZeneca